HALO logo
halo search icon
Mereo BioPharma Group plc Sponsored ADR
Mereo BioPharma Group plc Sponsored ADR
MREO · NAS

Mereo BioPharma Group plc Sponsored ADR

US$0.28

Price Arrow0.045 (18.78%)
20/05/2026 04:00:01 PM
All-ConsensusHammer Bullish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Mereo BioPharma Group plc Sponsored ADR Overview

MREO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MREO

icon

Telephone

44.333.023.7300

icon

Address

4th Floor, 1 Cavendish Place, London, Greater London W1G 0QF

Description

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.

MREO Price Chart

Key Stats

Market Cap

US$37.99M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.2 - 3.05

Trade Value (12mth)

US$977,909.00

1 week

-1.45%

1 month

-26.54%

YTD

-53.37%

1 year

-89.37%

All time high

8.48

Key Fundamentals

EPS 3 yr Growth

-24.60%

EBITDA Margin

NaN%

Operating Cashflow

-$31m

Free Cash Flow Return

-60.80%

ROIC

-82.20%

Interest Coverage

-154.00

Quick Ratio

10.50

Other Data

Shares Outstanding (Fully Diluted)

160m

HALO Sector

Healthcare

Next Company Report Date

31-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MREO Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
12 May 26
12 May 26
12 May 26

MREO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.2-0.29-0.26locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.2-0.29-0.26locklocklock
Growth
%locklocklocklock42.5-45.710locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Mereo BioPharma Group plc Sponsored ADR (MREO:NAS)?
Halo FAQ
The current share price of Mereo BioPharma Group plc Sponsored ADR (MREO:NAS) is USD$0.28.
What is the 52-week high share price for Mereo BioPharma Group plc Sponsored ADR (MREO:NAS)?
Halo FAQ
The 52-week high share price for Mereo BioPharma Group plc Sponsored ADR (MREO:NAS) is USD$3.05.
What is the 52-week low share price for Mereo BioPharma Group plc Sponsored ADR (MREO:NAS)?
Halo FAQ
The 52-week low share price for Mereo BioPharma Group plc Sponsored ADR (MREO:NAS) is USD$0.20.
What is the dividend yield for Mereo BioPharma Group plc Sponsored ADR (MREO:NAS)?
Halo FAQ
Mereo BioPharma Group plc Sponsored ADR (MREO:NAS) does not pay a dividend.
What was Mereo BioPharma Group plc Sponsored ADR (MREO:NAS) last dividend payment?
Halo FAQ
Mereo BioPharma Group plc Sponsored ADR (MREO:NAS) does not pay a dividend.
What is the franking level for Mereo BioPharma Group plc Sponsored ADR (MREO:NAS)?
Halo FAQ
Mereo BioPharma Group plc Sponsored ADR (MREO:NAS) has a franking level of 0.00%.
In which sector is Mereo BioPharma Group plc Sponsored ADR (MREO:NAS) classified?
Halo FAQ
Mereo BioPharma Group plc Sponsored ADR (MREO:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.